MYGN
Myriad Genetics Inc
3.90$
-6.0%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -7.1% | +2.4% | -1.6% | +2.1% | +14.4% | -34.6% | +24.0% | -1.8% | +11.0% | +11.2% | -1.6% | |
| – | +35.0% | +6.7% | +8.8% | +3.5% | +13.4% | -11.3% | +10.9% | +2.2% | +16.9% | +6.8% | -1.7% | |
| – | -13.9% | +1.3% | -4.4% | +1.6% | +14.8% | -41.7% | +30.1% | -3.4% | +8.5% | +13.2% | -1.5% | |
| – | +11.9% | -6.5% | +5.4% | -4.8% | +21.3% | -5.8% | +1.2% | +4.3% | +3.9% | +27.8% | -5.8% | |
| – | – | – | – | – | – | -8.9% | +6.0% | -53.9% | +14.4% | -2.7% | -6.9% | |
| – | +11.9% | -2.7% | +19.5% | -13.4% | +44.5% | +1.7% | +4.6% | -12.2% | +10.2% | +1.8% | -4.3% | |
| – | -51.1% | +14.3% | -71.3% | +177.0% | -93.8% | -2,663.2% | – | – | – | – | – | |
| – | – | +50.0% | +1,900.0% | -46.7% | +275.0% | -10.0% | -38.9% | -51.5% | -9.4% | -3.4% | +275.0% | |
| – | -51.5% | +15.6% | -76.8% | +231.8% | -93.6% | -3,784.4% | – | – | – | – | – | |
| – | -46.2% | -29.1% | -51.0% | -168.4% | – | – | – | – | – | +245.5% | -868.4% | |
| – | -54.5% | +46.1% | -85.2% | +666.1% | -96.5% | -4,963.0% | – | – | – | – | – | |
| – | -44.5% | +14.4% | -50.6% | +96.4% | -52.2% | -245.2% | – | -788.6% | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.